Myelodysplastic Syndromes Treatment in Turkey

Understanding Myelodysplastic Syndromes and Symptoms

Myelodysplastic syndromes (MDS) are a group of blood disorders caused by improperly formed or malfunctioning blood stem cells in the bone marrow. Instead of developing into healthy red blood cells, white blood cells, and platelets, these immature cells often die early or fail to enter the bloodstream. Over time, this leads to low blood cell counts, known as cytopenias, which reduce the body's ability to transport oxygen, fight off infections, and stop bleeding.

MDS predominantly affects older adults. In the early stages, it may cause no obvious signs and is sometimes picked up during routine blood tests requested during general Check-ups & Diagnostics. As the condition progresses, patients frequently experience persistent fatigue, pale skin, and shortness of breath due to anaemia. A drop in healthy white blood cells leads to frequent or unusually severe infections. Furthermore, low platelet counts cause easy bruising, frequent nosebleeds, or pinpoint red spots under the skin. In some individuals, MDS can progress to acute myeloid leukaemia, making early specialist evaluation within Oncology essential.

How MDS Is Diagnosed in Turkey

International patients travelling to Turkey for haematological evaluation undergo a thorough diagnostic process to confirm the diagnosis, classify the specific subtype of MDS, and calculate a prognostic risk score. Doctors need precise information to distinguish MDS from other bone marrow disorders, vitamin deficiencies, or drug side effects.

A comprehensive assessment typically includes:

• Full Blood Count (FBC) with Peripheral Blood Smear: To measure red cells, white cells, and platelets, and to examine the physical appearance of blood cells under a microscope.
• Bone Marrow Aspiration and Biopsy: A fluid sample and a small core of bone tissue are extracted, usually from the hip bone, to evaluate cellular structure and dysplasia in the marrow.
• Cytogenetic and Molecular Testing: Genetic analysis of the bone marrow cells to check for chromosome abnormalities (such as deletion 5q) and gene mutations, which guide risk stratification and treatment selection.
• Targeted Diagnostic Imaging: Scans such as abdominal ultrasound or chest imaging via Pulmonology & Thoracic Surgery specialists to check for enlarged organs or underlying infections.

Patients should bring all recent blood test results, bone marrow reports, medical imaging summaries, and a complete history of previous medication or chemotherapy treatments to their initial consultation.

Treatment Options for Myelodysplastic Syndromes

Management strategies for MDS depend on whether the disease is classified as lower-risk or higher-risk, based on international scoring systems. The main goals are to relieve symptoms, improve quality of life, manage blood counts, and reduce the likelihood of progression to leukaemia.

For patients experiencing complex gastrointestinal side effects from oral medications, coordinated care involving Gastroenterology specialists may be incorporated into the supportive care plan.

Planning Your Medical Travel to Turkey

Managing a bone marrow condition abroad requires careful scheduling and preparation. Before travelling, foreign medical records and lab reports are reviewed by the treating haematologist to determine whether immediate in-person testing is suitable. You should plan to stay in Turkey for at least two to three weeks to complete initial diagnostic re-evaluations, bone marrow biopsies, and early treatment cycles.

Patients undergoing bone marrow procedures or receiving blood transfusions must remain near the clinical facility until blood cell counts stabilize. Before returning home, your medical team provides a detailed discharge report detailing your exact diagnosis, cytogenetic results, and ongoing management plan. This document allows your local doctor to continue blood count monitoring, administer prescription drugs, or coordinate ongoing supportive therapies without interruption.

Travel Restrictions and Warning Signs

Air travel carries specific risks for individuals with severe blood count abnormalities. Extremely low hemoglobin levels increase the risk of cardiovascular distress in cabin pressures, while low platelet counts carry a risk of spontaneous bleeding. Patients with severely low white blood cell counts are vulnerable to severe infections acquired during transit. Fit-to-fly clearance must always be issued by the attending medical specialist after reviewing fresh blood tests.

Seek immediate, emergency local medical care rather than traveling if you experience any of the following warning signs:

• A fever over 38°C or sudden severe chills, which may indicate a life-threatening neutropenic infection.
• Uncontrolled bleeding, coughing up blood, or dark, tarry stools.
• Sudden chest pain, severe shortness of breath, or confusion.
• Rapidly worsening weakness or inability to stand.